| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_709e8e5e99bbea829e0addfb45d56ac3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f9c545d15dc8f2960aeeb1654c41f02c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_652fc711568ca60764739e213a38f2fd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f939f650bacf12d2766271bbece6fb97
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ff56cd68beba60f1f7768e1949ea8518 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-74 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-71
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-8257
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4718 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01H5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-04 |
| filingDate |
2005-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b491bc1a15813e85cf578d9f86eeb1ca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a0e1853fc15c6242c5b78c87e51ef11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4442f268e8f2d411650dab91c593f7c7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b9f880c2aedd6d2d200e0e97c51942b2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_76256bef256de9c8bb29f547f0a4cbfe |
| publicationDate |
2008-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2008280323-A1 |
| titleOfInvention |
Method for Producing Epidermal Growth Factor Using Fusion Proteins Comprising Fas-1 Domain |
| abstract |
The present invention provides a fusion protein in which a polypeptide comprising Fas-1 domain is fused in frame to N-terminal or C-terminal of human EGF, a nucleotide sequence encoding the fusion protein, an expression vector containing the nucleotide sequence, a transformant transformed by the nucleotide sequence and a method for producing human EGF, improving stability of the protein and enhancing the functions of the same. The present invention provides human EGF with improved stability and enhanced functions by fusing a polypeptide comprising Fas-1 domain having the activities of cell adhesion and wound healing to human EGF. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108586584-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104740677-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108864308-A |
| priorityDate |
2004-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |